HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor.

AbstractOBJECTIVE:
This study was undertaken to study the effectiveness of continuous subcutaneous terbutaline (SQT) in the home after recurrent preterm labor (RPTL).
STUDY DESIGN:
Women with RPTL at less than 32 weeks' gestation were treated with continuous SQT administered in the home compared with matched control patients.
RESULTS:
Fifteen SQT patients were compared with 45 women (3:1) treated with no tocolytic therapy after hospitalization. Gestational age at delivery more than 37 weeks (53% vs 4%), percentage delivered at less than 32 weeks (0% vs 47%), overall and pregnancy prolongation (49.8 +/- 19.2 days vs 24.5 +/- 12.8 days) were all significantly better in the study group (P <.001). The total number of maternal hospital days (9.8 +/- 2.1 vs 15.9 +/- 7.4, P <.0001), duration of NICU stay (1.9 +/- 4.9 vs 19.8 +/- 29.3 days, P <.001), and total cost for newborn care (6,995 +/- 14,822 US dollars vs 62,033 +/- 89,978 US dollars, P <.002) favored the study patients. For every dollar spent on SQT, there was a savings of 4.67 US dollars in newborn hospital costs for control patients.
CONCLUSION:
In this small study, the use of SQT significantly prolongs pregnancy, decreases serious neonatal complications, and reduces the duration of hospitalization for both mother and infant, as well as neonatal costs.
AuthorsJohn C Morrison, Suneet P Chauhan, C Shannon Carroll Sr, James A Bofill, Everett F Magann
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 188 Issue 6 Pg. 1460-5; discussion 1465-7 (Jun 2003) ISSN: 0002-9378 [Print] United States
PMID12824979 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Tocolytic Agents
  • Terbutaline
Topics
  • Adult
  • Australia
  • Cohort Studies
  • Female
  • Home Infusion Therapy (economics)
  • Hospital Costs
  • Humans
  • Infant, Newborn
  • Infusion Pumps
  • Injections, Subcutaneous
  • Intensive Care, Neonatal (economics)
  • Length of Stay
  • Obstetric Labor, Premature (economics, prevention & control)
  • Pregnancy
  • Recurrence
  • Terbutaline (administration & dosage, economics)
  • Tocolytic Agents (administration & dosage, economics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: